EyePoint Pharmaceuticals
EYPT
#5226
Rank
HK$11.47 B
Marketcap
HK$138.64
Share price
0.45%
Change (1 day)
101.36%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Cash on Hand

Cash on Hand as of September 2025 : HK$1.58 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has HK$1.58 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

EyePoint Pharmaceuticals - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$2.87 B11.37%
2023-12-31HK$2.58 B128.91%
2022-12-31HK$1.12 B-31.53%
2021-12-31HK$1.64 B373.84%
2020-12-31HK$0.34 B101.23%
2019-12-31HK$0.17 B
2018-06-30HK$0.30 B130.69%
2017-06-30HK$0.13 B-41.36%
2016-06-30HK$0.22 B1.71%
2015-06-30HK$0.22 B56.14%
2014-06-30HK$0.14 B77.79%
2013-06-30HK$79.67 M-29.51%
2012-06-30HK$0.11 B-39.8%
2011-06-30HK$0.18 B37.25%
2010-06-30HK$0.13 B155.88%
2009-06-30HK$53.46 M-56.07%
2008-06-30HK$0.12 B483.21%
2007-06-30HK$20.86 M-76.57%
2006-06-30HK$89.08 M17.1%
2005-06-30HK$76.07 M-55.22%
2004-06-30HK$0.16 B2647.88%
2003-06-30HK$6.18 M
2001-06-30HK$12.81 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
HK$17.26 M-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
HK$1.02 M-99.94% Bahamas